Precision Healthcare’s Fady Hannah-Shmouni on extending healthspan through mitigating genetic risks and advancing AI-driven endocrine care.
Dr Fady Hannah-Shmouni, an expert in endocrinology and longevity medicine, is at the forefront of integrating advanced technologies into healthspan science. Through his work in precision medicine and AI-driven healthcare solutions, he is aiming to redefine how we monitor, predict and optimize hormonal health to extend vitality and longevity. As the founder of Healthspan Digital Inc, he is spearheading the development of innovative tools – from AI-powered smart mirrors to modular multi-omics analysis platforms – that empower individuals and businesses to take a proactive approach to aging. His research and clinical work span genetic endocrinology, metabolic health and interventions aimed at bridging the gap between lifespan and healthspan.
The Global Healthspan Summit kicked off today in Riyadh; set to convene world leaders in science, investment and policy, discussions will focus on translating breakthroughs in aging research into real-world applications. Among the key panels, The Technology in Healthspan Exchange will bring together pioneers in AI, wearables, and digital health to chart the future of longevity technology.
Longevity.Technology: The role of digital health in longevity has never been more pressing, and Global Healthspan Summit provides a crucial platform for sharing breakthroughs. What innovations in digital health do you think will dominate discussions at the Summit?
Hannah-Shmouni explains that digital health technologies are poised to dominate discussions at the Global Healthspan Summit by showcasing their transformative potential in scaling longevity services.
“Tools like AI-powered diagnostics, wearable health monitors, and smart home devices are redefining proactive healthcare by enabling real-time health tracking and personalized interventions from the comfort of one’s home,” he says, adding that these technologies can also bridge gaps between patients and providers, fostering a more connected ecosystem.
“For instance, platforms integrating biomarkers of aging with AI analytics can empower both individuals and clinicians to make data-driven decisions, ultimately extending healthspan,” he explains.
The Summit is likely to emphasize how innovations like these can democratize access to longevity solutions globally, especially in underserved regions. “This is the future: precision, accessibility, and scalability,” says Hannah-Shmouni.
Hannah-Shmouni, who recently collaborated on the chapter Artificial Intelligence in Endocrinology in the book Artificial Intelligence in Clinical Practice, told us that AI is advancing endocrinology by enabling precision medicine at an unprecedented scale.
“It’s transforming how we diagnose, monitor, and treat endocrine disorders by leveraging machine learning algorithms to analyze complex datasets, such as genomic profiles, hormonal patterns, and imaging results,” he explains, offering the example of how AI can predict the onset of diabetes or thyroid dysfunction years before clinical symptoms appear, allowing for earlier intervention.
He adds that, moreover, AI-powered tools are enhancing patient care through personalized treatment plans.
“By integrating data from wearables, salivary hormone testing (like Eli Health’s platform), and other biomarkers, clinicians can tailor therapies to individual needs,” he explains. “This is particularly impactful in conditions like adrenal disorders or metabolic syndrome, where treatment often requires nuanced adjustments. The field is at the dawn of a new era, where AI not only augments clinical decision-making but also democratizes access to high-quality endocrine care globally, bridging gaps in healthcare equity.”
When it comes to emerging trends in endocrine research, Hannah-Shmouni explains that these are increasingly focused on targeting aging at the molecular level.
“These therapies hold promise for mitigating age-related hormonal decline and chronic diseases,” he says, highlighting therapies like GLP-1 receptor agonists and metformin, which are demonstrating significant benefits in extending healthspan beyond their original metabolic indications.
Salivary hormone testing, like that offered by Eli Health, is also gaining traction for its non-invasive, real-time monitoring capabilities, says Hannah-Shmouni, who explains these can optimize cortisol circadian rhythm and improve quality of life within minutes from sample collection.
“Together, these innovations are reshaping how we approach endocrine health to extend vitality and longevity.”
Genetic factors influence aging, of course, and can influence everything from cellular repair mechanisms to hormonal regulation.
“Variants in genes like FOXO3, associated with longevity, or those involved in telomere maintenance, can determine how well our bodies resist age-related decline,” explains Hannah-Shmouni. “However, even with ‘bad’ genes, lifestyle choices – nutrition, exercise, and stress management – can modify the trajectory of aging. Emerging interventions include gene therapies targeting senescence pathways, and AI-driven tools to identify genetic predispositions for chronic diseases, enabling earlier and more targeted interventions.”
Additionally, advancements in epigenetic reprogramming aim to reverse cellular aging by resetting gene expression patterns.
“In our longevity clinics, including ZOIME in Dubai, UAE, and Supernatural in Toronto, Canada, we use modular multi-omics analysis software, including NU Pro, to analyze large data sets for advanced and personalized recommendations,” explains Hannah-Shmouni. “These innovations, combined with proactive health measures, hold immense promise for extending healthspan and mitigating genetic risks.”
Healthspan Digital Inc, which was founded by Hannah-Shmouni is leveraging technology to promote healthy longevity by integrating advanced smart home tools into everyday life.
“We’ve developed products like AI-powered smart mirrors, that provide real-time health insights and personalized recommendations,” he explains. “These devices, combined with other smart technologies, enable proactive health management directly from home. Our Healthspan Hubs expand this vision by merging medical facilities, wellness centers, and research labs into turnkey solutions for businesses, offering services like biomarker testing, genetic analysis, and personalized health optimization.”
Looking ahead, Healthspan Digital aims to scale these hubs in clinics and real-estate communities, enhancing access to longevity services.
“The ultimate goal is to democratize healthspan advancements, making cutting-edge tools available to individuals and businesses worldwide to scale healthy longevity services.”
To watch the Global Healthspan Summit live today and tomorrow, please go to: www.hevolution.com
Originally published on Longevity.Technology – February 4, 2025. By Eleanor Garth.
